483 Vantage Specialty Ingredients Apr 2010

483 Vantage Specialty Ingredients Apr 2010

Atul Agrawal FDA, Nicholas Violand FDA, Barbara Wilimczyk-Macri FDA$119.00 - Available Now

FDA investigators audited the Vantage Specialty Ingredients - Linden, NJ, United States facility and issued inspectional observations (via FDA 483) on 08 Apr 2010.

Product details

  • Category: Human Drugs
  • Inspection end: 08 Apr 2010
  • Location: Linden, United States
  • FEI: 2210672
Add To Cart